Ecologists Ask Economists: Is The Price Right?

(The Scientist, Vol:10, #6, p. 11, March 18, 1996) One of my beloved grandmothers arrived in the United States as a penniless child. When I was a boy and showed her a good report card, she used to ask me with a smile: "If you're so smart, why aren't you rich?" I didn't know enough then to explain that some people are out of the cash economy, and that some productive assets are not priced by markets in a way that reflects their value to people. In other forms, her question has taken on larger

Written byJoel Cohen
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

(The Scientist, Vol:10, #6, p. 11, March 18, 1996)

Joel Cohen One of my beloved grandmothers arrived in the United States as a penniless child. When I was a boy and showed her a good report card, she used to ask me with a smile: "If you're so smart, why aren't you rich?"

I didn't know enough then to explain that some people are out of the cash economy, and that some productive assets are not priced by markets in a way that reflects their value to people. In other forms, her question has taken on larger significance in recent exchanges between economists and ecologists.

In December 1995, I published a book called How Many People Can the Earth Support? (New York, W.W. Norton and Co.). There I wrote: "Human numbers currently exceed 5.7 billion and increase by roughly an additional 90 million people per year. . . . The Earth's human ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies